| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 19.262 | 17.184 | 7.656 | 8.018 | 7.820 | 7.295 | 9.854 | 16.512 | 16.312 | 25.430 |
| Total Income - EUR | 19.262 | 18.597 | 7.656 | 8.018 | 7.821 | 28.191 | 16.930 | 20.377 | 22.377 | 27.891 |
| Total Expenses - EUR | 24.359 | 21.919 | 14.050 | 12.509 | 11.776 | 11.274 | 12.955 | 19.161 | 19.681 | 26.442 |
| Gross Profit/Loss - EUR | -5.096 | -3.323 | -6.393 | -4.491 | -3.955 | 16.916 | 3.974 | 1.216 | 2.696 | 1.449 |
| Net Profit/Loss - EUR | -5.674 | -3.509 | -6.470 | -4.571 | -4.033 | 16.638 | 3.805 | 1.012 | 2.473 | 1.170 |
| Employees | 3 | 2 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Medovistar S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 272 | 0 | 0 | 107 | 105 | 103 | 101 | 0 | 0 | 0 |
| Current Assets | 1.526 | 7.763 | 1.986 | 2.840 | 3.413 | 4.800 | 5.849 | 2.560 | 1.570 | 1.342 |
| Inventories | 268 | 420 | 1.903 | 2.653 | 3.381 | 4.586 | 5.775 | 2.253 | 1.510 | 1.073 |
| Receivables | 721 | 2.032 | 0 | 15 | 26 | 10 | 0 | 0 | 0 | 0 |
| Cash | 536 | 5.310 | 83 | 172 | 6 | 204 | 74 | 306 | 60 | 269 |
| Shareholders Funds | -8.601 | -12.022 | -18.288 | -22.524 | -26.120 | -8.988 | -4.984 | -3.987 | -1.502 | -323 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 10.398 | 19.785 | 20.274 | 25.471 | 29.639 | 13.892 | 10.934 | 6.547 | 3.072 | 1.665 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Medovistar S.r.l.